The following articles were read in the preparation of this document. Not all articles are sited.

1. Armor BL, Brtton ML. Diabetes mellitus non-glucose monitoring: point of care testing. Ann Pharmacother. 2004 June; 38(6): 1039 – 1047.
2. van den Besselaar AM. Accuracy, precision, and quality control for the point of care testing of oral anticoagulation. J Thromb Thrombolysis. 2001 sep; 12(1): 35 – 40.
3. Bevan VM, Bullock DG, Haeney M, Dhell J. The application of near patient testing to microbiology. Commun Dis Public Health. 1999; 2: 14 -21.
4. Bissell M. Point of care testing at the millennium. Crit Care Nurse Q. 2001 May; 24 (1): 39 – 43.
5. Cambell S, Howanitz PJ. Resident training in point of care testing. Clin Lab Med. 2007 Jun; 27(2) 397 – 410.
6. Creed GM. Point of care testing in the United Kingdom. Crit Care Nurs Q. 2001 May; 24(1): 44 – 48.
7. Delaney, BC, Hyde CJ, McManus RJ, Wilson S, Fitzmaurice DA, Jowett S, Tobias R, Thorpe GH, Hobbs FDR. Systematic review of near patient test evaluations in primary care. BMJ 1999 Sept; 319: 824 – 827.
8. Geyer SJ. Implementing an effective point-of-care testing programme. Crit Care Nurs Q 2001; 24(1): 7 – 14.
9. Guibert R, Schattner P, Sikaris P, Churiloz L, Leibowitz R, Matthews M. Review of the role and value of near patient testing in general practice. Report to the pathology section, Diagnostic and Technology Branch, Commonwealth Department of Health and Aged care. 2001.
10. Gutierres SL, Welty TE. Point of care testing: an introduction. Ann Pharmacother. 2004 Jan; 38(1): 119 – 125.
11. Hobbs FDR, Delaney BC, Fitzmaurice DA, Wislon S, Hyde CJ, Thorpe GH, Earl-Slater ASM, Jowett S, Tobias RS. A review of near patient testing in primary care. Health Technology Assessment. 1997; 5(1).
12. Hobbs FD, Fitzmaurice DA, Murray ET, Holder R, Rose PE, Roper JL. Is the interanational normalised ratio (INR) reliable? A trail of comparative measurements in hospital laboratory and primary care settings. J Clin Pathol. 1999 Jul; 52(7): 494 – 497.
13. Howanitz LH, Howanitz PJ. Laboratory results. Timeliness as a quality attribute and strategy. Am J Clin Pathol. 2001 sep; 116(3): 311 – 315.
14. Huckle D. Point of care diagnostics: will the hurdles be overcome this time? Exprt Rev Med Devices. 2006 Jul; 3(4): 421 – 426.
15. Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID. Emerging technologies and quality assurance: the United Kingdome National External Quality Assurance Scheme perspective. Semin Thromb Hemost. 2007 Apr; 33(3): 243 - 249.
16. Lehmann CA. The future of home testing – implications for traditional laboratories. Clin Chim Acta. 2002 Sep; 323(1-2): 31 – 36.
17. Males RG, Stephenson J, Harris P. Cardiac markers and point of care testing: a perfect fit. Crit Care Nurs Q. 2001 May; 24(1): 54 – 61.
18. Murray ET, Fitzmaurice DA, McCahon D. Point of care testing for INR monitoring: where are we now? Br J Haematol. 2004 Nov; 127(4): 373 – 378.
19. Nichols JH. Quality in point of care testing. Expert Rev Mol Diagn. 2003; 3(5): 563 – 572.
20. Nutescu EA. Point of care monitors for oral anticoagulant therapy. Semin Thromb Hemost. 2004 Dec; 30(6): 697 – 702.
21. Price CP. Medical and economic outcomes of point of care testing. Clin Chem Lab med. 2002 Mar; 40(3): 246 – 251.
22. Taylor JR, Lopez LM. Cholesterol: point of care testing. Ann Pharmacother. 2004 Jul-Aug; 38(7-8): 1252 – 1257.
23. Tripodi A, Breukink-Engbers WG, van den Besselaar AM. Semin Vasc Med. 2003 Aug; 3(3): 243 - 254.
24. Yang Z, Min Zhou D. Cardiac markers and their point of care testing for diagnosis of acute myocardial infarction. Clin Biochem. 206 Aug; 39(8): 771 – 780.